The phosphodiesterase 4 (PDE4) family, which specifically hydrolyzes intracellular cAMP, is composed by four isozymes (PDE4A, PDE4B, PDE4C and PDE4D) encoded by different gene loci, and each of them produces several mRNAs by alternative splicing (Houslay et al., 1998) .
These isozymes and their splice variants are widely expressed in many tissues including the brain (Pérez-Torres et al., 2000; McPhee et al., 2001; Miró et al., 2002; D'Sa et al., 2005) . The different knock out mice for PDE4B and PDE4D genes present unique phenotypes, (Jin et al., 1999; Jin and Conti, 2002; Jin et al., 2005) , which suggests different functions for these isozymes.
The majority of studies into PDE4 subtype distribution have focused upon inflammatory cells (Engels et al., 1994; Uhlig et al., 1997; Gantner et al., 1998) . PDE4A, PDE4B and PDE4D, are found to some extent in different inflammatory cell types, where they could be important regulators of inflammatory processes. Selective inhibitors of PDE4s have been suggested as therapies for the treatment of several human diseases (Menniti et al., 2006) , predominantly disorders of the immune and inflammatory systems (Teixeira et al., 1997) or disorders of the central nervous system, such as, depression (O'Donnell and Zhang, 2004) or Alzheimer's disease (McGeer and McGeer, 1995) .
The lipopolysaccharide (LPS) is a potent inflammatory agent that has been used to characterize the acute inflammatory process in the brain (Breder et al., 1994; Breder and Saper, 1996) . The efficacy of PDE4 inhibitors in inflammation models is remarkable and includes inhibition of LPS-induced increment in serum levels of tumour necrosis factor-α (TNF-α) in liver injury, lung injury, renal failure, mortality (Teixeira et al., 1997; Jin and Conti, 2002) or in a multiple sclerosis mouse model (Moore et al., 2006) .
The present study aims to determine the regional distribution in rat brain of the four PDE4B splice variants. The possible involvement of cAMP through PDE4B in inflammation prompted us to analyze the expression of the different PDE4 isozymes in the brain of LPS treated rats.
MATERIALS AND METHODS
Animal procedure was performed according to the European Union regulations (O.J. of E.C. L358/1 18/12/1986) and was approved by the Institutional Animal Care and Use Committee.
Adult male Wistar rats (200-300 g; Iffa Credo, Lyon, France) used for the neuroanatomical localization of PDE4B splicing variants expression were decapitated and the brain was removed, frozen on dry ice and kept at -20 ºC. LPS treatment was performed as follows: rats were injected intraperitoneally with vehicle or LPS (from Escherichia coli, serotype 055:B5, Sigma, St. Louis, MO, USA; 500 µg/kg of body weight) diluted in 300 µl of 0.9% sterile saline.
Four rats were sacrificed at each of 1, 2, 3 and 4 hr post injection. Eight control rats received an injection of 0.9% sterile saline, and were sacrificed four at each of 2 and 3 hr post injection.
Several oligonucleotides were synthesized for each splicing variant: PDE4B1, bp 383-427, and 506-550, AF202732; PDE4B2 bp 418-462, 520-564, 545-589, L27058; PDE4B3 bp 476-520, 556-600, 616-660, 700-744, U95748; PDE4B4 bp 171-215, 216-260, 264-308, AF202733. COX-2 mRNA oligonucleotides were complementary to bp 1848-1893, NM_017232. The mRNA regions for each PDE4B splice variants were chosen because they share no similarity with each other. Evaluation of the oligonucleotide sequences with basic local alignment search tool of EMBL and GenBank databases indicated that the probes do not present any significant similarity with mRNAs other than their corresponding targets in the rat. The specificity of the autoradiographic signal obtained in the in situ hybridization histochemistry experiments was confirmed by performing a series of routine controls (Pompeiano et al., 1992) 
RESULTS AND DISCUSSION

mRNA distribution of PDE4B splicing variants in rat brain
We used in situ hybridization histochemistry to study the distribution of the four PDE4B splicing variants at various coronal levels of the rat brain (Fig. 1) . Table I Interestingly, PDE4B1, PDE4B2 and PDE4B3 are detected in the area postrema whereas PDE4B4 is absent (or expressed at very low levels). This area has been implicated as a chemoreceptor trigger zone for emesis (Borinson H.L. and Wang, 1953; Carpenter et al., 1988) .
The emetic side effects of rolipram are well known, when used as an antidepressant, (Scott et al., 1991) . So too are those that other PDE4 inhibitors (such as roflumilast and cilomilast) produce in patients treated with them for asthma or chronic obstructive pulmonary disease (COPD) (Spina, 2003; Chung, 2006) . The fact that we found no expression of PDE4B4 mRNA in the rat area postrema (even though rodents do not vomit) and that it has been proposed that in humans PDE4B4 exon is unlikely to encode a protein (Shepherd et al., 2003) , points to the importance of determining the expression of PDE4 splice variants in this area and other related areas of the human brain. This will help to find candidate targets for specific splicing variant PDE4 inhibitors with no emetic side effects to treat the aforementioned diseases.
In the hippocampal formation all four isoforms are visualized in CA2 and CA3 fields. In the dentate gyrus the only splicing isoform found was PDE4B2. The basic circuitry of the hippocampus is a trisynaptic circuit (Brown and Zador, 1990) where the sensory inputs from the entorhinal cortex arrive at the granule cells of the dentate gyrus, whose main output -via mossy fiber axons-is the pyramidal neurons of CA3, that send their Schaffer collateral axons to pyramidal neurons of CA1. Some of the synapses of the hippocampus display a remarkable form of plasticity, long-term potentiation (LTP), that could be relevant to the mnemonic functions of this circuitry (Brown et al., 1988) , and is a leading candidate for a synaptic mechanism for rapid learning in mammals (Brown and Zador, 1990 ). This form of plasticity has been studied most in the mossy fiber and in the Schaffer collateral axons. Several authors (Barad et al., 1998; Bach et al., 1999; Rose et al., 2005) suggest that rolipram could enhance hippocampusdependent memory tasks, and reduce cognitive decline associated with neurodegenerative and psychiatric diseases. These studies together with our finding that PDE4B2 is the only splicing variant expressed in the dentate gyrus, suggest that it could be involved in LTP regulation in the mossy fiber axons. The findings of Ahmed and Frey (2003) that PDE4B3 is involved in the regulation of LTP in the hippocampus, do not invalidate our suggestion, since there are different mechanisms for the two LTP systems: the mossy fibers and the Schaffer collateral inputs.
PDE4B3 could be involved in the LTP of Schaffer collateral inputs, (which take place in the CA3
region where all the splicing variants of PDE4B are expressed) and PDE4B2, could be involved in the LTP system of the mossy fibers output, which originates in the dentate gyrus, where PDE4B2 is the only splicing form expressed.
Systemic administration of LPS: effects on the brain.
In order to study the effects of short-term systemic administration of LPS on the expression of PDE4 isozymes in rat brain, we measured the corresponding mRNA levels 1, 2, 3 and 4 hr after LPS treatment in 15 brain areas (including some circumventricular organs) for the 4 splicing variant mRNAs. In order to validate our inflammatory animal model, we analyzed COX-2 mRNA expression in LPS-brains, since COX-2 mRNA is up-regulated in endothelial and perivascular cells of rat and mouse brain blood vessels after LPS administration (Cao et al., 1997) . As expected, we found that COX-2 mRNA levels were considerably increased 2 hr after LPS injection in microvasculature and leptomeninges (Fig. 2) Finally, Bonferroni's test performed for each PDE in these regions showed an exclusively significant increase in mRNA expression of PDE4B2 in choroid plexus when comparing vehicle with 2 and 3 hours after LPS injection (p<0.01). In these animal groups mRNA presented a tendency to increase in the rest of the areas.
Upregulation in the expression of several mRNAs has been reported to occur in some of the brain areas we have measured, such as choroid plexus, leptomeninges, and some circumventricular organs (organum vasculosum of the lamina terminalis, median eminence and area postrema) in inflammatory models. Several authors have observed an overexpression of CD14 , TNF-α (Nadeau and Rivest, 1999; Quan et al., 1999) , COX-2 (Breder and Saper, 1996; or IKappaB-α (Quan et al., 1997) mRNAs in these regions after a peripheral injection of LPS. The upregulation of PDE4B2 mRNA we observed in the choroid plexus and circumventricular organs after LPS injection could be of interest, given the fact that they may be the sites where communication between peripheral immune system and the brain takes place. The potential role played by PDE4B in inflammation is suported by the work of Conti's group done in PDE4B knockout mice (Jin and Conti, 2002; Jin et al., 2005) . Those animals present a decreased responsiveness to LPS in many inflammatory cells: peripheral leukocytes and peritoneal macrophages are not able to secrete TNF-α after LPS stimulation.
To conclude, we have observed a differential distribution of the four splicing variants of PDE4B in the rat brain and a differential regulation for one of the PDE4B splicing variants, PDE4B2, in an inflammatory model. Additional experiments and the development of specific inhibitors for this isoform will help to elucidate its implication in the inflammatory reaction. mRNA data are expressed as semiquantitative estimates of hybridization intensity obtained by microdensitometric analysis of film autoradiograms. The levels of hybridization signals are: "+++" very strong; "++" moderate; "+" weak; "-/+" very weak and "-" not detected. "White matter" includes pyramidal tract, genu corpus callosum, cerebral peduncle and anterior commissure. peduncle; CPu, caudate putamen (striatum); DCo, dorsal cochlear nucleus; DG, dentate gyrus; gcc, genu of the corpus callosum; hil, hilus; LRt, lateral reticular nucleus; ME, median eminence; MG: medial genicular nucleus; MHb, medial habenular nucleus; 3, oculomotor nucleus; Pir, piriform cortex; Pn, pontine nuclei; PV, paraventricular thalamic nucleus; py, pyramidal tract; S1: primary somatosensory cortex. Bar = 3mm. 
